INTRODUCTION
Microspheres have gained wide acceptance as a means to achieve oral and parenteral controlled drug delivery systems. They often require a polymer as carrier as well as core material [1] . Among the various methods developed for the formulation of microspheres, the solvent evaporation method has gained much attention due to its ease of fabrication without compromising the activity of the drug.
Ethyl
cellulose, a non-ionic, inert hydrophobic, non-biodegradable and biocompatible polymer with minimal toxicity. It is one of the extensively studied encapsulating materials for the controlled release of pharmaceuticals [2] . HPMC is a non-ionic, swellable polymer. Hydrophilic polymer gel matrix systems are widely used in controlled drug delivery to obtain a desirable drug release profile and cost effectiveness because of their flexibility. The hydration rate of HPMC increases with increase in the hydroxypropyl content. Carbopol is a polymer consisting of acrylic acid cross-linked with either polyalkenyl ether or divinyl glycol. It readily absorbs water, gets hydrated and swell. In addition to its hydrophilic nature, cross-linked structure and insolubility in water, carbopol is an anionic polymer, and hence a potential candidate for use in controlled release drug delivery [3] .
The use of natural polymers is preferred due to their proven biocompatibility and safety. In this respect, chitosan, a cationic polymer, has attracted particular attention. It is biocompatible, biodegradable and bioadhesive at physiological pH and possesses OH and NH 2 groups that can give rise to hydrogen bonding. It is a high molecular weight polysaccharide, comprising of glucosamine and N-acetyl glucosamine obtained by deacetylation of chitin [4] . Because of its low production cost, non-toxic nature, and FDA approval, chitosan has found application in multiparticulate drug delivery [5] .
Diabetes mellitus (DM) is the name given to a group of disorders characterized by chronic hyperglycemia, polyurea, polydipsia, polyphagia, emaciation and weakness due to disturbance in carbohydrate, fat and protein metabolism associated with absolute or relative deficiency in insulin secretion and/or insulin action. A drug of choice, either alone or in combination with other hypoglycemic agents, particularly in Type II diabetes, metformin, is an effective antidiabetic drug, belonging to the biguanide class [6] .
EXPERIMENTAL Materials
Metformin hydrochloride was received as a gift from Sun Pharmaceuticals, Baroda, India. 
Preparation of microspheres
The microspheres containing the anti-diabetic drug, metformin, as the core material were prepared by a non-aqueous solvent evaporation method [7] . Here, the drug (250 mg) and the polymers (250, 500, or 750 mg) were mixed in acetone (8 ml) at various ratios. The slurry was introduced into 30 ml of liquid paraffin while stirring (600, 1200 or 1800 rpm) with a mechanical stirrer equipped with a three-blade propeller at room temperature. The solution was stirred for 4 h to allow the solvent to evaporate and the microspheres were collected by filtration by Whatman filter paper no.
1. The microspheres were washed repeatedly with petroleum ether (40 -60 °C) until free from oil. The microspheres were collected and dried for 3 h at room temperature and subsequently stored in a desiccator over fused calcium chloride.
The effect of process variables including drug/polymer ratio, stirring rate and polymer type on mean microsphere size, drug entrapment efficiency, yield, drug content, micromeritic properties and drug release was studied. Metformin microspheres were prepared in varying drug/polymer ratio (see Table 1 ) while keeping stirring speed (1200 rpm) constant. Similarly, microspheres were prepared at various stirring rates (i.e., 600, 1200 and 1800 rpm) while keeping drug/polymer ratio constant at 1:2.
Evaluation of micromeritic properties of microspheres
The microspheres were characterized for their micromeritic propertiesangle of repose, bulk density, tapped density, Carr's index, and Hausner's ratio [7, 8] . Angle of repose (θ) of different formulations was measured according to the fixed funnel standing method (n = 3) and calculated using Eq 1. θ = tan -1 h/r …………………….
(1) where r is the radius of the cone base, and h the height of the base.
Bulk and tapped densities were measured using a 10 ml graduated cylinder. The sample placed in the cylinder and the volume (bulk) noted. The cylinder was then,tapped 100 times and the volume (tapped) again noted. The bulk and tapped densities were calculated were calculated from the ratio of the weight and volume as appropriate. Compressibility (Carr's) index (Ci) of microparticles was computed according to Eq 2. Ci = (Dt -Db)/ Dt × 100 ………….... (2) where Dt is tapped density and Db the bulk density.
Hausner's ratio of the microparticles was determined as in Eq 3.
Hausner's ratio = Dt/Db …………… (3)
Morphology and particle size
The shape and surface characteristics of the microspheres were studied using scanning electron microscope (SEM, LEO -430, Leo Electron Microscopy Ltd., Cambridge, England). The microparticles were coated uniformly with gold-palladium by using a sputter coater (Polaron SC-76430) after fixing the sample in individual stubs. The operating parameters were an acceleration voltage of 20kV and chamber pressure of 0.6 mm Hg (n = 3). Size distribution based on mean diameter of the microspheres was determined by optical microscopy method [8, 9] . Approximately, 100 microspheres were counted using a calibrated optical microscope (Magnus MLX-DX) and mean particle size was calculated.
Evaluation of entrapment efficiency, drug loading and yield
Microspheres (50 mg) were treated with 50 ml. of phosphate buffer (pH 6.8), in 100 ml. amber coloured vial with stirring at 250 rpm. The temperature was maintained at 37 ± 0.2 ºC. At the end of 2 h, it was filtered and the filtrate analyzed spectrophotometrically (n = 3) at 232 nm (Shimadzu, Pharmspec UV-1700 series, Japan). Drug entrapment efficiency, drug loading and yield were were calculated using Eqs 4 -6 [10].
Drug entrapment (%) = (A/T)100 ….. (4) where A is actual drug concentration and T is the theoretical drug concentration.
Drug loading (%) = (Wd/Wm)100 …… (5) where Wd is the weight of drug and Wm the weight of the microspheres.
Yield (%) = (Wm/Wdp)100 …………... (6) where Wdp is the expected total weight of drug and polymer.
In-vitro drug release studies
The in-vitro drug release profiles of the various microsphere formulations were studied in 900 ml of buffer in simulated gastrointestinal pH conditions, viz, simulated gastric fluid (0.1M HCl, pH 1.2) for the first 2 h followed by 4 h in simulated intestinal fluid (phosphate buffer solution, PBS, pH 6.8) and finally for 9 h in simulated intestinal fluid (phosphate buffer solution, PBS, pH 7.4) [11] . Samples (5 ml) were withdrawn at various time intervals, and replaced with the same volume of test medium to maintain sink conditions. The withdrawn samples were diluted, where necessary, filtered through a 0.45µ membrane filter and analyzed for metformin content at 232 nm using Shimadzu spectrophotometer (Pharmspec UV-1700 series, Japan).
Statistical analysis
Experimental results (n = 3) were expressed as mean ± S.D. One-way ANOVA was performed using Sigma Stat software (SPSS Inc, USA) for Windows, version 2.30. Differences were considered significant at p < 0.05.
RESULTS

Particle characteristics
Scanning electron microphotographs showed that the microspheres were spherical with a smooth to rough surface (Fig 1) . Pores were observed on the microsphere surface. Increasing polymer concentrations (i.e., drugpolymer ratio from 1:1 to 1:3) increased microsphere size from 352.1 ± 7.5 to 374.2 ± 7.8 μm for ethylcellulose, 359.3 ± 4.1 to 388.4 ± 8.8 μm for HPMC, 424.5 ± 8.6 to 450.3 ± 8.8 μm for carbopol 934P, and 408.6 ± 10.6 to 426.8±8.2 μm for chitosan. However, in all cases, the increase was not significant (p > 0.05).
Increase in stirring rate from 600 rpm to 1800 rpm also seemed to have decreased microsphere size but the decrease was not significant (p > 0.05).
Fig 1:
Scanning electron microphotographs (SEM) of metformin microspheres prepared with HPMC using solvent evaporation method
Microsphere yield was > 56.8 % for all the formulations while entrapment efficiency (%) ranged 56.4 ± 2.4 to 85.4 ± 3.4 for EC microspheres, 68.1 ± 4.2 to 85.5 ± 3.9 for HPMC microspheres, 64.1 ±4.8 to 85.2 ± 5.3 for CA microspheres and 61.2 ± 3.3 to 83.5 ± 5.1 for CH microspheres (Table 1 ).
Micromeritic properties of microspheres
All the formulations showed angle of repose in the range of 25° to 34°. Compressibility, i.e., Carr's index, was between 11.0 and 15.5 % and Hausner's ratio < 1.2, all the parameters indicating good flow property. Of particular note are formulations EC5 and CA5 which showed the best flow properties ( Table  2) .
In-vitro drug release of microspheres
Drug release (for 1:3 drug/polymer ratio) after 15 h was in the rank order: carbopol 934P > HPMC > ethyl cellulose > chitosan (Fig 2) , with the formulation prepared with carbopol 934P releasing approximately 94.8 % of drug after 15 h. Key: EC = ethylcellulose, HPMC = hydroxypropyl methylcellulose, CA = carbopol 934P, and CH = chitosan, microspheres 
DISCUSSION
Increase in polymer concentration from 1:1 to 1:3 (drug:polymer) increased yield and entrapment efficiency probably because with increasing polymer content, more particles of metformin would be coated leading to higher encapsulation efficiency [12] . However, this increase was not significant.
The pores on the microsphere surface of some formulations indicate leaching of the drug during dissolution prior to gelation of the polymeric surface. It was observed that as the drug-polymer concentration increased, the percentage entrapment efficiency increased whereas the percentage yield decreased.
Increase in the particle size of the microspheres can be attributed to increase in viscosity with increasing polymer concentrations, which resulted in large emulsion droplets [13, 14] . Shearing efficiency during stirring also diminishes at higher viscosities, thus resulting in the formation of larger droplets and hence bigger particles [15] .
As drug:polymer ratio was varied from 1:1 to 1:3, with the consequent increase in the polymer content, drug release rate gradually decreased. The increased density of the polymer matrix at higher polymer concentrations results in increased diffusional pathway decreasing overall drug release from the polymer matrix [17] . Furthermore, smaller microspheres formed at lower polymer concentrations have a larger surface area exposed to the dissolution medium, thus leading faster drug release. The microspheres prepared with EC, HPMC and CA completely released the drug after 12 h. However, sustained drug release was observed for microspheres formulated with chitosan polymer extending to 15 h.
The drug release was slower at acid pH than at alkaline pH. However, when chitosan was used as the polymer, more drug was released (34 %) at acid pH in 2 h at a stirring speed of 1800 rpm. This is due to the increased solubility of chitosan at acid pH.
CONCLUSION
Varying degrees of sustained metformin release were obtained for microspheres formulated EC, HPMC, CA and CH with CH microspheres being the most drug sustaining of them all. Therefore, the developed formulations, prepared by non-aqueous solvent evaporation method, are promising for the sustained oral delivery of metformin hydrochloride.
